0
0
0
Expressing the sense of the House of Representatives that the Food and Drug Administration has the authority to approve drugs for abortion care.
12/15/2023, 3:51 PM
Summary of Bill HRES 309
Bill 118 HRES 309, titled "Expressing the sense of the House of Representatives that the Food and Drug Administration has the authority to approve drugs for abortion care," is a resolution that was introduced in the US Congress. The purpose of this resolution is to affirm the belief that the Food and Drug Administration (FDA) has the authority to approve drugs that are used for abortion care.
The resolution emphasizes the importance of ensuring that the FDA is able to fulfill its regulatory responsibilities in a timely and efficient manner, particularly when it comes to approving drugs that are used for abortion care. It also highlights the need for the FDA to base its decisions on scientific evidence and medical expertise, rather than political considerations.
The resolution does not seek to change any existing laws or regulations related to abortion care. Instead, it simply expresses the opinion of the House of Representatives that the FDA should be able to carry out its duties without interference or obstruction. Overall, Bill 118 HRES 309 is a non-binding resolution that serves to reaffirm the belief that the FDA has the authority to approve drugs for abortion care. It is a statement of support for the FDA's regulatory role in ensuring the safety and efficacy of medications used in abortion procedures.
The resolution emphasizes the importance of ensuring that the FDA is able to fulfill its regulatory responsibilities in a timely and efficient manner, particularly when it comes to approving drugs that are used for abortion care. It also highlights the need for the FDA to base its decisions on scientific evidence and medical expertise, rather than political considerations.
The resolution does not seek to change any existing laws or regulations related to abortion care. Instead, it simply expresses the opinion of the House of Representatives that the FDA should be able to carry out its duties without interference or obstruction. Overall, Bill 118 HRES 309 is a non-binding resolution that serves to reaffirm the belief that the FDA has the authority to approve drugs for abortion care. It is a statement of support for the FDA's regulatory role in ensuring the safety and efficacy of medications used in abortion procedures.
Congressional Summary of HRES 309
This resolution expresses the sense of the House of Representatives that the Food and Drug Administration (FDA) has the authority to review and approve drugs pursuant to its own expertise, and that recent court decisions blocking the FDA's approval of mifepristone (which is used in medication abortion) violate congressional intent with respect to the FDA's authority.
Read the Full Bill
Current Status of Bill HRES 309
Bill HRES 309 is currently in the status of Bill Introduced since April 19, 2023. Bill HRES 309 was introduced during Congress 118 and was introduced to the House on April 19, 2023. Bill HRES 309's most recent activity was Referred to the House Committee on Energy and Commerce. as of April 19, 2023
Bipartisan Support of Bill HRES 309
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
96Democrat Cosponsors
96Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HRES 309
Primary Policy Focus
HealthAlternate Title(s) of Bill HRES 309
Expressing the sense of the House of Representatives that the Food and Drug Administration has the authority to approve drugs for abortion care.
Expressing the sense of the House of Representatives that the Food and Drug Administration has the authority to approve drugs for abortion care.
Comments
Sponsors and Cosponsors of HRES 309
Latest Bills
Ratepayer Protection Act
Bill HR 9340September 17, 2026
To designate the facility of the United States Postal Service located at 825 Highway 198 in Beaumont, Mississippi, as the "Jeremy Malone Post Office".
Bill HR 6995September 17, 2026
To designate the facility of the United States Postal Service located at 298 Route 292 in Holmes, New York, as the "Sheriff Adrian "Butch" Anderson Post Office Building".
Bill HR 1008September 17, 2026
To designate the facility of the United States Postal Service located at 417 West 7th Street in Columbia, Tennessee, as the "Pharmacist’s Mate First Class John Harlan Willis Post Office Building".
Bill HR 6808September 17, 2026
To designate the facility of the United States Postal Service located at 14855 South Van Dyke Road in Plainfield, Illinois, as the "Staff Sergeant Jose Dueñez Jr. Post Office Building".
Bill HR 6020September 17, 2026
To designate the facility of the United States Postal Service located at 300 Macedonia Lane in Knoxville, Tennessee, as the "Reverend Harold Middlebrook Post Office Building".
Bill HR 1372September 17, 2026
To designate the facility of the United States Postal Service located at 3570 Olney Laytonsville Road in Olney, Maryland, as the "Edward L. Ramsey Olney Post Office Building".
Bill HR 6310September 17, 2026
To designate the facility of the United States Postal Service located at 12208 North 19th Avenue in Phoenix, Arizona, as the "Officer Zane T. Coolidge Post Office".
Bill HR 3393September 17, 2026
To designate the facility of the United States Postal Service located at 13355 North Lon Adams Road in Marana, Arizona, as the "Mayor Ed Honea Memorial Post Office".
Bill HR 6247September 17, 2026
To designate the facility of the United States Postal Service located at 130 South Patterson Avenue in Santa Barbara, California, as the "Brigadier General Frederick R. Lopez Post Office Building".
Bill HR 2175September 17, 2026